337
Views
3
CrossRef citations to date
0
Altmetric
Research Articles

The use of novel tools for the assessment of powders and granules flow properties and for the analysis of minitablets compression process

, , , , &
Pages 547-556 | Received 14 Jan 2020, Accepted 16 Feb 2020, Published online: 04 Mar 2020

References

  • Aleksovski A, Dreu R, Gašperlin M, et al. Mini-tablets: a contemporary system for oral drug delivery in targeted patient groups. Expert Opin Drug Deliv. 2015;12(1):65–84.
  • European Medicines Agency. Regulation (EC) No. 1901/2006 on medicinal products for paediatric use and amending. Off J Eur Union. 2006;L378/1.
  • Spomer N, Klingmann V, Stoltenberg I, et al. Acceptance of uncoated mini-tablets in young children: results from a prospective exploratory cross-over study. Arch Dis Child. 2012;97(3):283–286.
  • Klingmann V, Spomer N, Lerch C, et al. Favorable acceptance of mini-tablets compared with syrup: a randomized controlled trial in infants and preschool children. J Pediatr. 2013;163(6):1728–1732.
  • Kluk A, Sznitowska M, Brandt A, et al. Can preschool-aged children swallow several minitablets at a time? Results from a clinical pilot study. Int J Pharm. 2015;485(1–2):1–6.
  • Klingmann V, Seitz A, Meissner T, et al. Acceptability of uncoated mini-tablets in neonates—a randomized controlled trial. J Pediatr. 2015;167(4):893–896.
  • Ranmal SR, Cram A, Tuleu C. Age-appropriate and acceptable paediatric dosage forms: insights into end-user perceptions, preferences and practices from the Children’s Acceptability of Oral Formulations (CALF) Study. Int J Pharm. 2016;514(1):296–307.
  • Klingmann V. Acceptability of mini-tablets in young children: results from three prospective cross-over studies. AAPS PharmSciTech. 2017;18(2):263–266.
  • Mistry P, Batchelor H. Evidence of acceptability of oral paediatric medicines: a review. J Pharm Pharmacol. 2017;69(4):361–376.
  • Klingmann V, Linderskamp H, Meissner T, et al. Acceptability of multiple uncoated minitablets in infants and toddlers: a randomized controlled trial. J Pediatr. 2018;201:202–207.
  • van Riet-Nales DA, Ferreira JA, Schobben A, et al. Methods of administering oral formulations and child acceptability. Int J Pharm. 2015;491(1–2):261–267.
  • Thabet Y, Walsh J, Breitkreutz J. Flexible and precise dosing of enalapril maleate for all paediatric age groups utilizing orodispersible minitablets. Int J Pharm. 2018;541(1–2):136–142.
  • Lopez FL, Ernest TB, Orlu M, et al. The effect of administration media on palatability and ease of swallowing of multiparticulate formulations. Int J Pharm. 2018;551(1–2):67–75.
  • European Medicines Agency. Reflection paper on the pharmaceutical development of medicines for use in the older population; 2017; [cited 2019 Aug 8]. Available from: https://www.ema.europa.eu/en/pharmaceutical-development-medicines-use-older-population
  • Czajkowska M, Kotlowska H, Madanecka A, et al. Prolonged-release minitablets with carbamazepine – preliminary observations in vitro. J Pharm Pharmacol. 2017;69:471–479.
  • Yeleken G, Kotlowska H, Sznitowska M, et al. Development of direct compressed loratadine minitablets. J Pharm Sci Res. 2017;9:401–406.
  • Rumondor ACF, Harris D, Flanagan F, et al. Minitablets: manufacturing, characterization methods, and future opportunities. Am Pharm Rev. 2016;19:36.
  • Tissen C, Woertz K, Breitkreutz J, et al. Development of mini-tablets with 1 mm and 2 mm diameter. Int J Pharm. 2011;416(1):164–170.
  • Goh HP, Heng PWS, Liew CV. Understanding die fill variation during mini-tablet production. Int J Pharm. 2017;534(1–2):279–286.
  • Goh HP, Sia Heng PW, Liew CV. The effects of feed frame parameters and turret speed on mini-tablet compression. J Pharm Sci. 2019;108(3):1161–1171.
  • Zhao J, Yin D, Rowe J, et al. Understanding the factors that control the quality of mini-tablet compression: flow, particle size, and tooling dimension. J Pharm Sci. 2018;107(4):1204–1208.
  • European Directorate for the Quality of Medicines, 2.9.49. Powder flow properties by shear cell methods. Pharmeuropa. 2018;30(1):19–25.
  • Yu LX. Pharmaceutical quality by design: product and process development, understanding and control. Pharm Res. 2008;25(4):781–791.
  • Yu LX, Kopcha M. The future of pharmaceutical quality and the path to get there. Int J Pharm. 2017;528(1–2):354–359.
  • Sidorchuk A, Isomura K, Molero Y, et al. Benzodiazepine prescribing for children, adolescents, and young adults from 2006 through 2013: a total population register-linkage study. PLoS Med. 2018;15(8):e1002635.
  • Bogunovic OJ, Greenfield SF. Practical geriatrics: use of benzodiazepines among elderly patients. Psychiatr Serv. 2004;55(3):233–235.
  • Wilson S, Houpt M. Project USAP 2010: use of sedative agents in pediatric dentistry—a 25-year follow-up survey. Pediatr Dent. 2016;38(2):127–133.
  • User manual: powder flow analyser. Surrey (UK): Stable Micro Systems; 2016.
  • Shah RB, Tawakkul MA, Khan MA. Comparative evaluation of flow for pharmaceutical powders and granules. AAPS PharmSciTech. 2008;9(1):250–258.
  • Chen KS, Pearn WL. An application of non-normal process capability indices. Qual Reliab Eng Int. 1997;13(6):355–360.
  • European Pharmacopoeia 9.8, Directorate for the Quality of Medicines of the Council of Europe, Strasbourg; 2019. 2.9.5 Uniformity of mass of single-dose preparations.
  • Burgess C. Process stability, performance, and capability; what is the difference? Pharm Technol. 2018;42:64–67.
  • Beakawi Al-Hashemi HM, Baghabra Al-Amoudi OS. A review on the angle of repose of granular materials. Powder Technol. 2018;330:397–417.
  • Yaginuma Y, Ozeki Y, Kakizawa M, et al. Effects of powder flowability on die-fill properties in rotary compression. J Drug Deliv Sci Technol. 2007;17(3):205–210.
  • Augsburger LL, Hoag SW. Pharmaceutical dosage forms. New York (NY): Informa Healthcare; 2008.
  • Manley L, Hilden J, Valero P, et al. Tablet compression force as a process analytical technology (PAT): 100% inspection and control of tablet weight uniformity. J Pharm Sci. 2019;108(1):485–493.
  • Montgomery DC. Introduction to statistical quality control. New York (NY): John Wiley & Sons; 2005.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.